SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

Bullish analyst coverage has put TeraWulfs AI/HPC data-center pivot and contracted power capacity in focus, while a more cautious view highlights execution and pipeline risks. Traders are split between the long-term AI infrastructure thesis and concerns over the stocks steep pullback, insider transactions, and perceived short-selling pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on bearish sentiment around Trump-linked market and policy concerns, including the Iran conflict, high fuel costs, tariffs, and rising interest rates, alongside criticism of DJTs decline and weak company fundamentals. A smaller group frames the move as a buying opportunity, but bearish comments dominate.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos quarterly results beat expectations, but the shares barely moved as traders debated whether strong underlying sales and digital growth justify the premium valuation, particularly with part of the earnings boost coming from one-time tariff refunds. Bulls point to resilient demand, while skeptics focus on the slower pace of core comparable sales and limited room for valuation expansion.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Traders are linking QNTs rally to reports that Quant was selected to support The Clearing Houses tokenized-deposit initiative, reinforcing its banking-interoperability narrative; the Robinhood listing is also cited as a source of attention. The reaction is broadly bullish, with low-supply and short-squeeze speculation, though some traders warn the move could pull back.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally centers on its Phase 3 personalized melanoma cancer-vaccine trial with Merck, which met its main endpoints; traders are focused on the full data presentation at ESMO and CEO comments about the broader oncology pipeline. Bullish momentum and short-squeeze chatter contrast with skepticism that the results justify the valuation or will translate into scalable commercial success.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

ONDOs sharp rally is being linked by traders to Ondos launch of tokenized investment portfolios powered by BlackRock, reinforcing enthusiasm for its real-world-asset tokenization business. Some investors are bullish on the institutional tie-up, while others question whether growth benefits ONDO token holders without a fee-sharing mechanism and warn of profit-taking after the run-up.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars steep selloff and fresh 52-week low are drawing attention amid analyst downgrades and concerns about limited visibility into future bookings, with higher rates and solar-policy uncertainty adding pressure. Traders are split between viewing the decline as an oversold buying opportunity and expecting further losses; some also speculate about short-selling or China-related policy risks.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile shares are under pressure after traders highlighted JPMorgans target cut tied to a softer service-revenue outlook ahead of Q3, alongside fresh 52-week-low talk. The community is split between bearish concerns about further downside and investors treating the pullback as a buying opportunity.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Attention is centered on Novavaxs C. difficile vaccine program, with traders reacting to reported encouraging preclinical results and manufacturing preparations as signs the candidate could advance toward human trials. Bulls see this as validation of the Matrix-M platform, while skeptics question managements execution; short-squeeze speculation also remains prominent.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs preclinical SLS009 pancreatic-cancer posters at the AACR conference are drawing attention, alongside anticipation of the REGAL Phase 3 GPS trials 80th-event trigger and final results. Bulls view the pipeline and prolonged trial timeline as encouraging, while skeptics question the REGAL evidence and caution that the pancreatic posters are preclinical, not clinical results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera (BFRI) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of +70.59% and +33.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates

BioStem Technologies, Inc. (BSEM) delivered earnings and revenue surprises of -4.00% and +23.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of -50.00% and +10.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +18.18% and -80.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of +26.32% and +16.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera (BFRI) Q1 2026 Earnings Transcript

Transcript: Biofrontera Q1 2026 Earnings Conference Call

Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of -127.78% and +6.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of +10.00% and -59.76%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Current Price	$1.20
Prev Close	$1.15
Open	$1.16
Dividend Yield	0.00%
50-Day Moving Average	$1.31
Beta	0.78
Avg. Volume	579,645.37
PE Ratio	-2.05

52-Week High	$1.66
52-Week Low	$0.5547
Market Capitalization	$17.08M
EPS (Annual)	-$1.04
Price to Book	2.86
Revenue Per Employee	$453,315.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

BFRI Fundamentals